Cumulus Oncology Ltd. raised $50M in a series A funding round to develop novel drug targets for clinical use.

Sep 03, 2024•over 1 year ago

Amount Raised

$50 Million

Round Type

series a

EdinburghBiopharmaTherapeuticsPharmaceuticalBiotechnologyHealth Care

Description

Cumulus Oncology Ltd. is in the process of raising a $50 million series A round aimed at sourcing and developing new drug targets from academia. This funding will support their ongoing efforts in clinical development and startup creation.

Company Information

Company

Cumulus Oncology

Location

Edinburgh, Scotland, United Kingdom

About

Cumulus Oncology Ltd. is a biopharmaceutical company focused on sourcing novel drug targets emerging from academia and developing them for clinical use. The company specializes in creating startups from its discoveries. Cumulus is currently raising funds to support its growth and development initiatives. Their work is centered around cancer treatment advancements.

Related People

4 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Cumulus Oncology Ltd. raised $50M in a series A funding round to develop novel drug targets for clinical use.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information